A review of ophthalmology education in the era of generative artificial intelligence

2024-8-1

Development of Oculomics Artificial Intelligence for Cardiovascular Risk Factors: A Case Study in Fundus Oculomics for HbA1c Assessment and Clinically Relevant Considerations for Clinicians

2024-8-1

Cybersecurity in the Generative Artificial intelligence Era

2024-8-1

Latest Developments of Generative Artificial Intelligence and Applications in Ophthalmology

2024-8-1

Longitudinal imaging of 8-year progression in a teenager with Stargardt disease

2024-8-1

Artificial intelligence for Retinal Diseases

2024-8-1

Upholding Artificial Intelligence Transparency in Ophthalmology: A Call for Collaboration between Academia, Industry, and Government for Patient Care in the 21st Century

2024-8-1

Development and testing of Artificial Intelligence based mobile application to achieve cataract backlog-free status in Uttar Pradesh, India

2024-8-1

An unusual iris in Waardenburg syndrome

2024-7-1

The role of saliency maps in enhancing ophthalmologists’ trust in artificial intelligence models

2024-7-1

Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives

2024-7-1

Natural Language Processing in medicine and ophthalmology: A review for the 21st-century clinician

2024-7-1

Response: Comment on "Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination"

2024-7-1

Deep Learning‐Enabled Vasculometry Depicts Phased Lesion Patterns in High Myopia Progression

2024-7-1

Understanding natural language: Potential application of large language models to ophthalmology

2024-7-1

Diversity, equity and inclusion in curriculum vitae for medical and surgical specialty training college entrance

2024-7-1

Comment on “Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination”

2024-6-1

Transition probabilities of diabetic retinopathy and death in an Asian population with Diabetes

2024-5-1

Response: Comment on “Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial”

2024-5-1

Syphilitic scleritis and episcleritis: A review

2024-5-1

Comment on “Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial”

2024-5-1

Response to Letter to the Editor: “Discrepancies in reported prevalence rates of keratoconus in Russia”

2024-5-1

Diabetic retinopathy

2024-5-1

Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis

2024-5-1

Discrepancies in Reported Prevalence Rates of Keratoconus in Russia

2024-5-1

Etiology including epigenetic defects of retinoblastoma

2024-5-1

Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study

2024-5-1

Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy

2024-5-1

Genetic Association of TIE2 with Diabetic Retinopathy and Diabetic Macular Edema

2024-5-1

Immediate versus Delayed sequential bilateral ICL implantation: a retrospective comparison of vault height and visual outcomes

2024-5-1

Long-term Efficacy and Safety of Posterior Endoscopic Cyclophotocoagulation in Refractory Glaucoma: A 5-Year Follow-up Study at a Tertiary Eye Center

2024-5-1

Exaggerated Immune Response to Fungal Keratitis Post-COVID-19 Vaccination

2024-4-1

Concealed retro-iridic multi-cavitary melanoma revealed by ultrasound biomicroscopy

2024-3-18

Diffuse preretinal vitreous seeding as a recurrence of uveal melanoma

2024-3-1

Vitreous metastasis from cutaneous melanoma while on checkpoint inhibitors

2024-3-1

Navigating the Spectrum: A Comprehensive Exploration of Diverse Ocular and Orbital Tumor Entities

2024-3-1

Intravascular Large B-cell Lymphoma of the Eye: Literature Review and New Findings

2024-3-1

Targeted Therapy in Ophthalmic Oncology: The Current Status

2024-3-1

Masquerade Syndrome: A Review of Uveitic Imposters

2024-3-1

UVEAL MELANOMA: CURRENT EVIDENCE ON PROGNOSIS, TREATMENT AND POTENTIAL DEVELOPMENTS

2024-3-1

Recent progress in Retinoblastoma: Pathogenesis, Presentation, Diagnosis and Management

2024-3-1

Bilateral Diffuse Uveal Melanocytic Proliferation Secondary to Combined Hepatocellular-cholangiocarcinoma

2024-3-1

Topical 5-fluorouracil 1% for Moderate to Extensive Ocular Surface Squamous Neoplasia in 73 Consecutive Patients: Primary Versus Secondary Treatment

2024-3-1

Updates on eyelid cancers

2024-3-1

Metastatic renal cell carcinoma masquerading as an endogenous endophthalmitis: Role of vitreous cytology

2024-3-1

Update on Chemotherapy Modalities for Retinoblastoma: Progress and Challenges

2024-3-1

An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification – a prospective study

2024-2-1

Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma

2024-2-1

Subretinal drusenoid deposits, age-related macular degeneration, and cardiovascular disease

2024-1-1

Perioperative intense pulsed light to prevent and improve symptoms of post-laser corneal refractive surgery dry eye. A randomized clinical trial

2024-1-1